AA
BSX icon

Addison Advisors’s Boston Scientific BSX Stock Holding History

Addison Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1K Sell
49
-121
-71% -$6.57K ﹤0.01% 574
2026
Q1 		$10.7K Buy
170
+133
+359% +$10.6K ﹤0.01% 654
2025
Q4 		$3.53K Sell
37
-6
-14% -$588 ﹤0.01% 736
2025
Q3 		$4.2K Sell
43
-9
-17% -$932 ﹤0.01% 722
2025
Q2 		$5.59K Sell
52
-29
-36% -$2.93K ﹤0.01% 693
2025
Q1 		$8.17K Buy
81
+45
+125% +$4.53K ﹤0.01% 609
2024
Q4 		$3.22K Buy
36
+25
+227% +$2.2K ﹤0.01% 714
2024
Q3 		$922 Sell
11
-12
-52% -$946 ﹤0.01% 776
2024
Q2 		$1.77K Sell
23
-24
-51% -$1.76K ﹤0.01% 698
2024
Q1 		$3.22K Buy
+47
New +$3.02K ﹤0.01% 600
2023
Q1 		– Sell
-21
Closed -$972 – 647
2022
Q4 		$972 Sell
21
-12
-36% -$520 ﹤0.01% 617
2022
Q3 		$1K Hold
33
– – ﹤0.01% 589
2022
Q2 		$1K Hold
33
– – ﹤0.01% 576
2022
Q1 		$1K Buy
33
+8
+32% +$347 ﹤0.01% 609
2021
Q4 		$1K Buy
+25
New +$1.05K ﹤0.01% 558

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Addison Advisors's BSX Position: Q2 2026 in Review

Addison Advisors reduced its Boston Scientific (BSX) stake by 71% in Q2 2026, selling an estimated $6.57K and leaving 49 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Addison Advisors first reported a position in BSX in Q4 2021 and has held it in 15 quarters since. The position peaked at $10.7K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Addison Advisors held 49 shares of Boston Scientific worth $2.1K as of Q2 2026.
  • Addison Advisors sold 121 Boston Scientific shares in Q2 2026, an estimated $6.57K.
  • Boston Scientific made up ﹤0.01% of Addison Advisors's portfolio in Q2 2026, its #574 holding.
  • Addison Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 15 quarters since.
  • Addison Advisors's Boston Scientific position peaked at $10.7K in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.